Moreover, in examination of GLS2 expression in 144 cases of human cervical cancer specimens (58 radioresistant samples+86 radiosensitive samples) and 15 adjacent normal tissues, Xiang and colleagues identified GLS2 expression was significantly elevated in tumor specimens obtained from radioresistant patients [29]. The gene discussed is GLS2; the disease is cervical cancer.